When can organoids help pharma make the leap from mice to human biology?
Brian Buntz
For decades, the loudest voices against animal testing in drug development belonged to animal rights groups and organizations like PETA. The pharmaceutical industry largely tuned them out while committing to the three Rs, which include Replacement, Reduction and Refinement of preclinical testing processes. So it was striking to see FDA encouraging drug developers to plan… The post When can organoids help pharma make the leap from mice to human biology? appeared first on Research & Development Wo